By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Transkaryotic Therapies, Inc. 

700 Main Street

Cambridge  Massachusetts  02139  U.S.A.
Phone: 617-349-0200 Fax: 617-613-4004


SEARCH JOBS


Industry
Biotechnology


Collaborations

Aventis Pharma AG  Dynepo (GA-EPO)

Sumitomo Pharmaceuticals Co. Ltd.  Fabry disease





Company News
Amgen (AMGN) Wins Transkaryotic Therapies, Inc. (TKTX) Appeal 8/3/2006 1:18:45 PM
Transkaryotic Therapies, Inc. (TKTX) Achieves GA-GCB Clinical Milestone10/19/2005 5:13:13 PM
Transkaryotic Therapies, Inc. (TKTX) Release: New Website Offers Comprehensive Information On Hunter Syndrome10/19/2005 5:13:09 PM
Transkaryotic Therapies, Inc. (TKTX) Announces Appointment Of Eric Pauwels As Senior Vice President, Global Commercial Operations10/19/2005 5:13:09 PM
Transkaryotic Therapies, Inc. (TKTX) To Present At Two Upcoming Healthcare Conferences10/19/2005 5:13:06 PM
Shire Pharmaceuticals Group plc To Build On Specialty Portfolio Through Acquisition Of Transkaryotic Therapies, Inc. (TKTX) For $1.6 Billion 10/19/2005 5:13:02 PM
Transkaryotic Therapies, Inc. (TKTX) To Present At SG Cowen & Co., LLC Securities' 25th Annual HealthCare Conference10/19/2005 5:12:58 PM
Transkaryotic Therapies, Inc. (TKT) (TKTX) Release: Strong Year Of Execution Produces Solid 2004 Financial Performance10/19/2005 5:12:49 PM
Tamara L. Joseph Named General Counsel Of Transkaryotic Therapies, Inc. (TKT) (TKTX)10/19/2005 5:12:44 PM
Transkaryotic Therapies, Inc. (TKT) (TKTX) To Report Fourth Quarter And Year-End 2004 Financial Results On February 23, 200510/19/2005 5:12:41 PM
12345678
//-->